Kamada (NASDAQ:KMDA) Sees Large Volume Increase – Here’s Why

Shares of Kamada Ltd. (NASDAQ:KMDA) saw an uptick in trading volume on Friday . Approximately 79,100 shares changed hands during mid-day trading, an increase of 2% from the previous session’s volume of 77,826 shares.The stock last traded at $8.8010 and had previously closed at $8.67.

Wall Street Analysts Forecast Growth

Several research firms recently commented on KMDA. Weiss Ratings lowered shares of Kamada from a “buy (b)” rating to a “buy (b-)” rating in a report on Thursday, June 25th. Wall Street Zen upgraded Kamada from a “hold” rating to a “strong-buy” rating in a research report on Saturday, August 15th. William Blair set a $15.00 price objective on Kamada in a research report on Tuesday, July 21st. Benchmark reissued a “buy” rating on shares of Kamada in a research note on Tuesday, July 21st. Finally, UBS Group reaffirmed a “buy” rating and issued a $15.00 target price on shares of Kamada in a research note on Friday. Four research analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus target price of $13.50.

Kamada Trading Up 2.0%

The firm has a market cap of $508.45 million, a P/E ratio of 23.28, a P/E/G ratio of 0.67 and a beta of 0.88. The business’s 50-day moving average is $7.67 and its two-hundred day moving average is $7.90.

Kamada (NASDAQ:KMDA) last released its quarterly earnings data on Wednesday, August 12th. The biotechnology company reported $0.16 earnings per share for the quarter, topping analysts’ consensus estimates of $0.11 by $0.05. The business had revenue of $54.92 million for the quarter, compared to analysts’ expectations of $50.84 million. Kamada had a net margin of 11.60% and a return on equity of 8.37%. On average, analysts anticipate that Kamada Ltd. will post 0.49 earnings per share for the current year.

Kamada Cuts Dividend

The company also recently disclosed an annual dividend, which was paid on Thursday, September 17th. Stockholders of record on Thursday, August 27th were given a dividend of $0.17 per share. The ex-dividend date was Thursday, August 27th. This represents a dividend yield of 206.0%. Kamada’s payout ratio is currently 34.21%.

Institutional Investors Weigh In On Kamada

An institutional investor recently raised its stake in Kamada stock. Aristides Capital LLC boosted its holdings in Kamada Ltd. (NASDAQ:KMDA) by 4.5% during the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 34,491 shares of the biotechnology company’s stock after acquiring an additional 1,476 shares during the quarter. Aristides Capital LLC owned 0.06% of Kamada worth $288,000 at the end of the most recent reporting period. 20.38% of the stock is currently owned by institutional investors.

About Kamada

Kamada Ltd. is an Israel-based biopharmaceutical company focused on the development, manufacture and commercialization of plasma-derived and specialty pharmaceutical products. The company’s portfolio is aimed primarily at treating rare diseases and other conditions requiring replacement or immune-modulating therapies.

Kamada’s principal product is GLASSIA, an intravenous alpha-1 proteinase inhibitor used as augmentation therapy in adults with alpha-1 antitrypsin deficiency, a rare genetic disorder that can cause progressive lung disease.